$GATO
Gatos Silver, Inc.

2021 Q2 Form 10-Q Financial Statement

#000110465921102116 Filed on August 09, 2021

View on sec.gov

Income Statement

Concept 2021 Q2 2020 Q2
Revenue $0.00 $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $4.411M $2.420M
YoY Change 82.27%
% of Gross Profit
Research & Development $694.0K $1.480M
YoY Change -53.11%
% of Gross Profit
Depreciation & Amortization $4.000K $1.190M
YoY Change -99.66% 0.85%
% of Gross Profit
Operating Expenses $5.112M $5.090M
YoY Change 0.43%
Operating Profit
YoY Change
Interest Expense $18.29M -$8.140M
YoY Change -324.71%
% of Operating Profit
Other Income/Expense, Net $312.0K -$765.0K
YoY Change -140.78%
Pretax Income $13.49M -$13.92M
YoY Change -196.92%
Income Tax
% Of Pretax Income
Net Earnings $13.49M -$12.14M
YoY Change -211.09%
Net Earnings / Revenue
Basic Earnings Per Share $0.23 -$0.30
Diluted Earnings Per Share $0.22 -$0.30
COMMON SHARES
Basic Shares Outstanding 59.75M 40.51M
Diluted Shares Outstanding 60.62M 40.51M

Balance Sheet

Concept 2021 Q2 2020 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $29.61M $2.000M
YoY Change 1380.35%
Cash & Equivalents $29.61M $1.954M
Short-Term Investments
Other Short-Term Assets $2.190M $3.400M
YoY Change -35.59%
Inventory $100.0K
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $37.18M $15.50M
YoY Change 139.9%
LONG-TERM ASSETS
Property, Plant & Equipment $48.00K $29.00M
YoY Change -99.83%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $247.3M $91.50M
YoY Change 170.3%
Other Assets $48.00K $300.0K
YoY Change -84.0%
Total Long-Term Assets $247.4M $90.49M
YoY Change 173.37%
TOTAL ASSETS
Total Short-Term Assets $37.18M $15.50M
Total Long-Term Assets $247.4M $90.49M
Total Assets $284.6M $106.0M
YoY Change 168.47%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $369.0K $100.0K
YoY Change 269.0%
Accrued Expenses $2.059M $2.400M
YoY Change -14.21%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $10.00M
YoY Change -100.0%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $3.781M $13.00M
YoY Change -70.92%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities $1.500M
YoY Change
Total Long-Term Liabilities $0.00 $1.500M
YoY Change -100.0%
TOTAL LIABILITIES
Total Short-Term Liabilities $3.781M $13.00M
Total Long-Term Liabilities $0.00 $1.500M
Total Liabilities $3.781M $14.50M
YoY Change -73.92%
SHAREHOLDERS EQUITY
Retained Earnings -$135.6M
YoY Change
Common Stock $108.0K
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost) $1.027M
YoY Change
Treasury Stock Shares $144.6K
Shareholders Equity $280.8M $121.6M
YoY Change
Total Liabilities & Shareholders Equity $284.6M $136.1M
YoY Change 109.08%

Cashflow Statement

Concept 2021 Q2 2020 Q2
OPERATING ACTIVITIES
Net Income $13.49M -$12.14M
YoY Change -211.09%
Depreciation, Depletion And Amortization $4.000K $1.190M
YoY Change -99.66% 0.85%
Cash From Operating Activities -$1.305M -$4.820M
YoY Change -72.93% 12.88%
INVESTING ACTIVITIES
Capital Expenditures $0.00
YoY Change -100.0%
Acquisitions
YoY Change
Other Investing Activities -$2.775M -$4.990M
YoY Change -44.39% -73.94%
Cash From Investing Activities -$2.775M -$4.990M
YoY Change -44.39% -74.51%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 2.651M 10.21M
YoY Change -74.04% -59.91%
NET CHANGE
Cash From Operating Activities -1.305M -4.820M
Cash From Investing Activities -2.775M -4.990M
Cash From Financing Activities 2.651M 10.21M
Net Change In Cash -1.429M 400.0K
YoY Change -457.25% -75.31%
FREE CASH FLOW
Cash From Operating Activities -$1.305M -$4.820M
Capital Expenditures $0.00
Free Cash Flow -$4.820M
YoY Change 25.52%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Entity Central Index Key
EntityCentralIndexKey
0001517006
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2021
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Amendment Flag
AmendmentFlag
false
CY2020Q4 us-gaap Stockholders Equity Note Stock Split Conversion Ratio1
StockholdersEquityNoteStockSplitConversionRatio1
0.5
CY2020Q4 us-gaap Stockholders Equity Note Stock Split Conversion Ratio1
StockholdersEquityNoteStockSplitConversionRatio1
0.5
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2021-06-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-39649
dei Entity Registrant Name
EntityRegistrantName
GATOS SILVER, INC.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
27-2654848
dei Entity Address Address Line1
EntityAddressAddressLine1
8400 E. Crescent Parkway, Suite 600
dei Entity Address City Or Town
EntityAddressCityOrTown
Greenwood Village
dei Entity Address State Or Province
EntityAddressStateOrProvince
CO
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
80111
dei City Area Code
CityAreaCode
303
dei Local Phone Number
LocalPhoneNumber
784-5350
dei Security12b Title
Security12bTitle
Common Stock, par value $0.001 per share
dei Trading Symbol
TradingSymbol
GATO
dei Security Exchange Name
SecurityExchangeName
NYSE
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
dei Entity Ex Transition Period
EntityExTransitionPeriod
true
dei Entity Shell Company
EntityShellCompany
false
CY2020Q2 us-gaap Costs And Expenses
CostsAndExpenses
1763000
us-gaap Costs And Expenses
CostsAndExpenses
8946000
us-gaap Costs And Expenses
CostsAndExpenses
2779000
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
20992000
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2020Q4 us-gaap Common Stock Value
CommonStockValue
108000
CY2021Q2 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
18291000
CY2020Q2 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-8071000
CY2021Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
68704201
CY2021Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
29607000
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
150146000
CY2021Q2 us-gaap Deferred Finance Costs Current Net
DeferredFinanceCostsCurrentNet
285000
CY2021Q2 us-gaap Due From Related Parties Current
DueFromRelatedPartiesCurrent
5102000
CY2020Q4 us-gaap Due From Related Parties Current
DueFromRelatedPartiesCurrent
1727000
CY2021Q2 us-gaap Other Assets Current
OtherAssetsCurrent
2190000
CY2020Q4 us-gaap Other Assets Current
OtherAssetsCurrent
3879000
CY2021Q2 us-gaap Assets Current
AssetsCurrent
37184000
CY2020Q4 us-gaap Assets Current
AssetsCurrent
155752000
CY2021Q2 us-gaap Investments In Affiliates Subsidiaries Associates And Joint Ventures
InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
247326000
CY2020Q4 us-gaap Investments In Affiliates Subsidiaries Associates And Joint Ventures
InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
109597000
CY2021Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
48000
CY2020Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
61000
CY2021Q2 us-gaap Assets
Assets
284558000
CY2020Q4 us-gaap Assets
Assets
265410000
CY2021Q2 us-gaap Accounts Payable And Other Accrued Liabilities Current
AccountsPayableAndOtherAccruedLiabilitiesCurrent
3781000
CY2020Q4 us-gaap Accounts Payable And Other Accrued Liabilities Current
AccountsPayableAndOtherAccruedLiabilitiesCurrent
4024000
CY2021Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2020Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2021Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
700000000
CY2020Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
700000000
CY2021Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
59774201
CY2020Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
59183076
CY2021Q2 us-gaap Common Stock Value
CommonStockValue
108000
CY2021Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
417248000
CY2020Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
409728000
CY2021Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-135552000
CY2020Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-147423000
CY2021Q2 us-gaap Treasury Stock Shares
TreasuryStockShares
144589
CY2020Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
144589
CY2021Q2 us-gaap Treasury Stock Value
TreasuryStockValue
1027000
CY2020Q4 us-gaap Treasury Stock Value
TreasuryStockValue
1027000
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
280777000
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
261386000
CY2021Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
284558000
CY2020Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
265410000
CY2021Q2 us-gaap Exploration Expense
ExplorationExpense
694000
CY2020Q2 us-gaap Exploration Expense
ExplorationExpense
211000
us-gaap Exploration Expense
ExplorationExpense
918000
us-gaap Exploration Expense
ExplorationExpense
382000
CY2021Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
4411000
CY2020Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1543000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
8014000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2380000
CY2021Q2 us-gaap Adjustment For Amortization
AdjustmentForAmortization
7000
CY2020Q2 us-gaap Adjustment For Amortization
AdjustmentForAmortization
9000
us-gaap Adjustment For Amortization
AdjustmentForAmortization
14000
us-gaap Adjustment For Amortization
AdjustmentForAmortization
17000
CY2021Q2 us-gaap Costs And Expenses
CostsAndExpenses
5112000
CY2021Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
1559000
CY2021Q1 us-gaap Adjustments To Additional Paid In Capital Other
AdjustmentsToAdditionalPaidInCapitalOther
-262000
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-1620000
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-21516000
CY2021Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
312000
CY2020Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-765000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-175000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-2345000
CY2021Q2 gato Nonoperating Income Expense And Interest And Debt Expense
NonoperatingIncomeExpenseAndInterestAndDebtExpense
18603000
CY2020Q2 gato Nonoperating Income Expense And Interest And Debt Expense
NonoperatingIncomeExpenseAndInterestAndDebtExpense
-8836000
gato Nonoperating Income Expense And Interest And Debt Expense
NonoperatingIncomeExpenseAndInterestAndDebtExpense
20817000
gato Nonoperating Income Expense And Interest And Debt Expense
NonoperatingIncomeExpenseAndInterestAndDebtExpense
-23861000
CY2021Q2 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
13491000
CY2020Q2 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
-10599000
us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
11871000
us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
-26640000
CY2020Q2 us-gaap Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
-1545000
us-gaap Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
-3325000
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
13491000
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
-12144000
us-gaap Net Income Loss
NetIncomeLoss
11871000
us-gaap Net Income Loss
NetIncomeLoss
-29965000
CY2021Q2 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
0.23
CY2020Q2 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
-0.26
us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
0.20
us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
-0.66
CY2020Q2 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
-0.04
us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
-0.08
CY2021Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.23
CY2020Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.30
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.20
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.74
CY2021Q2 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
0.22
CY2020Q2 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
-0.26
us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
0.20
us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
-0.66
CY2020Q2 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
-0.04
us-gaap Income Loss From Discontinued Operations Net Of Tax Per Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
-0.08
CY2021Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.22
CY2020Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.30
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.20
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.74
CY2021Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
59747048
CY2020Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
40506144
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
59611062
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
40505611
CY2021Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
60623496
CY2020Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
40506144
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
60420811
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
40505611
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
261386000
CY2021Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1078000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-7895000
us-gaap Increase Decrease In Accounts Receivable Related Parties
IncreaseDecreaseInAccountsReceivableRelatedParties
3333000
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-528000
gato Deferred Financing Costs Included In Accrued Liabilities
DeferredFinancingCostsIncludedInAccruedLiabilities
149000
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-766000
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
262141000
CY2021Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2490000
CY2021Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
2662000
CY2021Q2 us-gaap Adjustments To Additional Paid In Capital Other
AdjustmentsToAdditionalPaidInCapitalOther
-7000
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
13491000
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
280777000
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
149391000
CY2020Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1031000
CY2020Q1 us-gaap Stock Issued During Period Value Conversion Of Units
StockIssuedDuringPeriodValueConversionOfUnits
61000
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
-17821000
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
132662000
CY2020Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1086000
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
-12144000
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
121604000
us-gaap Profit Loss
ProfitLoss
11871000
us-gaap Profit Loss
ProfitLoss
-29965000
us-gaap Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
-3325000
us-gaap Adjustment For Amortization
AdjustmentForAmortization
14000
us-gaap Adjustment For Amortization
AdjustmentForAmortization
17000
us-gaap Share Based Compensation
ShareBasedCompensation
3426000
us-gaap Share Based Compensation
ShareBasedCompensation
2001000
us-gaap Income Loss From Equity Method Investments Net Of Dividends Or Distributions
IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions
20992000
us-gaap Income Loss From Equity Method Investments Net Of Dividends Or Distributions
IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions
-21516000
us-gaap Increase Decrease In Accounts Receivable Related Parties
IncreaseDecreaseInAccountsReceivableRelatedParties
3375000
us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
1689000
us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
70000
us-gaap Cash Provided By Used In Operating Activities Discontinued Operations
CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations
-2262000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-9537000
us-gaap Payments To Acquire Interest In Subsidiaries And Affiliates
PaymentsToAcquireInterestInSubsidiariesAndAffiliates
116595000
us-gaap Payments To Acquire Interest In Subsidiaries And Affiliates
PaymentsToAcquireInterestInSubsidiariesAndAffiliates
7573000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-116595000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-7573000
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
10000000
us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
269000
us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
588000
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
4221000
us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-1000
us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
260000
us-gaap Cash Provided By Used In Financing Activities Discontinued Operations
CashProvidedByUsedInFinancingActivitiesDiscontinuedOperations
307000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
3951000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
9979000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-120539000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-7131000
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
150146000
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
9085000
CY2020Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
40506144
CY2021Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
29607000
CY2020Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1954000
CY2020Q2 us-gaap Disposal Group Including Discontinued Operation Cash
DisposalGroupIncludingDiscontinuedOperationCash
380000
CY2021Q2 gato Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Continuing Operation
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsContinuingOperation
29607000
CY2020Q2 gato Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Continuing Operation
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsContinuingOperation
1574000
gato Deferred Financing Costs Included In Accrued Liabilities
DeferredFinancingCostsIncludedInAccruedLiabilities
284000
gato Director Compensation
DirectorCompensation
61000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
60420811
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
40505611
CY2021Q2 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
0.23
CY2020Q2 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
-0.26
us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
0.20
us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
-0.66
gato Percentage Of Royalty Payments On Net Semler Returns
PercentageOfRoyaltyPaymentsOnNetSemlerReturns
0.01
CY2021Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
369000
CY2020Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
560000
CY2021Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
2059000
CY2020Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1240000
CY2021Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
1093000
CY2020Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
1964000
CY2021Q2 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
260000
CY2020Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
260000
CY2021Q2 us-gaap Accounts Payable And Other Accrued Liabilities Current
AccountsPayableAndOtherAccruedLiabilitiesCurrent
3781000
CY2020Q4 us-gaap Accounts Payable And Other Accrued Liabilities Current
AccountsPayableAndOtherAccruedLiabilitiesCurrent
4024000
CY2021Q2 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
13491000
CY2020Q2 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
-10599000
us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
11871000
us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
-26640000
CY2020Q2 us-gaap Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
-1545000
us-gaap Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
-3325000
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
13491000
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
-12144000
us-gaap Net Income Loss
NetIncomeLoss
11871000
us-gaap Net Income Loss
NetIncomeLoss
-29965000
CY2021Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
59747048
CY2020Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
40506144
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
59611062
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
40505611
CY2021Q2 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
876448
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
809749
CY2021Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
60623496
CY2020Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
50000000
CY2020Q2 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
-0.04
us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
-0.08
CY2021Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.23
CY2020Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.30
CY2021Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2020Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
489719
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
798333
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
4221000
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.20
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.74
CY2021Q2 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
0.22
CY2020Q2 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
-0.26
us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
0.20
us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
-0.66
CY2020Q2 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
-0.04
us-gaap Income Loss From Discontinued Operations Net Of Tax Per Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
-0.08
CY2021Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.22
CY2020Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.30
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.20
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.74
CY2021Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
700000000
CY2020Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
700000000
CY2021Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2020Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2021Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
50000000
CY2021Q2 us-gaap Exploration Expense
ExplorationExpense
694000
CY2020Q2 us-gaap Exploration Expense
ExplorationExpense
211000
CY2021Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
4411000
CY2020Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1543000
CY2021Q2 us-gaap Adjustment For Amortization
AdjustmentForAmortization
7000
CY2020Q2 us-gaap Adjustment For Amortization
AdjustmentForAmortization
9000
CY2021Q2 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
18291000
CY2020Q2 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-8071000
CY2021Q2 us-gaap Gain Loss On Investments
GainLossOnInvestments
-312000
CY2020Q2 us-gaap Gain Loss On Investments
GainLossOnInvestments
765000
CY2021Q2 us-gaap Assets
Assets
284558000
CY2020Q2 us-gaap Assets
Assets
105991000
us-gaap Exploration Expense
ExplorationExpense
918000
us-gaap Exploration Expense
ExplorationExpense
382000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
8014000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2380000
us-gaap Adjustment For Amortization
AdjustmentForAmortization
14000
us-gaap Adjustment For Amortization
AdjustmentForAmortization
17000
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
20992000
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-21516000
us-gaap Gain Loss On Investments
GainLossOnInvestments
175000
us-gaap Gain Loss On Investments
GainLossOnInvestments
2345000
CY2021Q2 us-gaap Assets
Assets
284558000
CY2020Q2 us-gaap Assets
Assets
105991000

Files In Submission

Name View Source Status
0001104659-21-102116-index-headers.html Edgar Link pending
0001104659-21-102116-index.html Edgar Link pending
0001104659-21-102116.txt Edgar Link pending
0001104659-21-102116-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
gato-20210630.xsd Edgar Link pending
gato-20210630x10q.htm Edgar Link pending
gato-20210630x10q003.jpg Edgar Link pending
gato-20210630x10q_htm.xml Edgar Link completed
gato-20210630xex10d1.htm Edgar Link pending
gato-20210630xex31d1.htm Edgar Link pending
gato-20210630xex31d2.htm Edgar Link pending
gato-20210630xex32d1.htm Edgar Link pending
gato-20210630_cal.xml Edgar Link unprocessable
gato-20210630_def.xml Edgar Link unprocessable
gato-20210630_lab.xml Edgar Link unprocessable
gato-20210630_pre.xml Edgar Link unprocessable
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending